Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and it is one of the leading cause of disability worldwide. The most common types of arthritis includes: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, are among others.
Growing burden of incidence of osteoarthritis, psoriatic arthritis and rheumatoid arthritis patients are major factors driving the growth of global arthritis drugs market. According to CDC estimation from 2010-2012, about 52.5 million US adults had some form of arthritis conditions among them persons with age 65 or older reported higher prevalence of arthritis conditions than the other ages due to “wear and tear” on the joints. However, due to lack of proper medication to cure arthritis and higher cost of the medications are hindering the growth of this market over the forecast period.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Arthritis Drug market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Arthritis Drug market. Detailed analysis of key players, along with key growth strategies adopted by Arthritis Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
F Hoffmann-La Roche
Pfizer
Eli Lilly
GSK
Novartis
Johnson & Johnson
Celltrion
By Type:
Synthetic DMARDs
Biological DMARDs
NSAIDs
Corticosteroids
Analgesics
By End-User:
Retail Pharmacies
Hospital Pharmacies
Drug Stores
E-Commerce
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Arthritis Drug Market
-
1.3 Market Segment by Type
-
1.3.1 China Arthritis Drug Market Size and Growth Rate of Synthetic DMARDs from 2016 to 2027
-
1.3.2 China Arthritis Drug Market Size and Growth Rate of Biological DMARDs from 2016 to 2027
-
1.3.3 China Arthritis Drug Market Size and Growth Rate of NSAIDs from 2016 to 2027
-
1.3.4 China Arthritis Drug Market Size and Growth Rate of Corticosteroids from 2016 to 2027
-
1.3.5 China Arthritis Drug Market Size and Growth Rate of Analgesics from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Arthritis Drug Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
1.4.2 China Arthritis Drug Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027
-
1.4.3 China Arthritis Drug Market Size and Growth Rate of Drug Stores from 2016 to 2027
-
1.4.4 China Arthritis Drug Market Size and Growth Rate of E-Commerce from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Arthritis Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Arthritis Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Arthritis Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Arthritis Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Arthritis Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Arthritis Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Arthritis Drug Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Arthritis Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Arthritis Drug by Major Types
-
3.4.1 Market Size and Growth Rate of Synthetic DMARDs
-
3.4.2 Market Size and Growth Rate of Biological DMARDs
-
3.4.3 Market Size and Growth Rate of NSAIDs
-
3.4.4 Market Size and Growth Rate of Corticosteroids
-
3.4.5 Market Size and Growth Rate of Analgesics
4 Segmentation of Arthritis Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Arthritis Drug by Major End-Users
-
4.4.1 Market Size and Growth Rate of Arthritis Drug in Retail Pharmacies
-
4.4.2 Market Size and Growth Rate of Arthritis Drug in Hospital Pharmacies
-
4.4.3 Market Size and Growth Rate of Arthritis Drug in Drug Stores
-
4.4.4 Market Size and Growth Rate of Arthritis Drug in E-Commerce
5 Market Analysis by Regions
-
5.1 China Arthritis Drug Production Analysis by Regions
-
5.2 China Arthritis Drug Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Arthritis Drug Landscape Analysis
-
6.1 North China Arthritis Drug Landscape Analysis by Major Types
-
6.2 North China Arthritis Drug Landscape Analysis by Major End-Users
7 Central China Arthritis Drug Landscape Analysis
-
7.1 Central China Arthritis Drug Landscape Analysis by Major Types
-
7.2 Central China Arthritis Drug Landscape Analysis by Major End-Users
8 South China Arthritis Drug Landscape Analysis
-
8.1 South China Arthritis Drug Landscape Analysis by Major Types
-
8.2 South China Arthritis Drug Landscape Analysis by Major End-Users
9 East China Arthritis Drug Landscape Analysis
-
9.1 East China Arthritis Drug Landscape Analysis by Major Types
-
9.2 East China Arthritis Drug Landscape Analysis by Major End-Users
10 Northeast China Arthritis Drug Landscape Analysis
-
10.1 Northeast China Arthritis Drug Landscape Analysis by Major Types
-
10.2 Northeast China Arthritis Drug Landscape Analysis by Major End-Users
11 Southwest China Arthritis Drug Landscape Analysis
-
11.1 Southwest China Arthritis Drug Landscape Analysis by Major Types
-
11.2 Southwest China Arthritis Drug Landscape Analysis by Major End-Users
12 Northwest China Arthritis Drug Landscape Analysis
-
12.1 Northwest China Arthritis Drug Landscape Analysis by Major Types
-
12.2 Northwest China Arthritis Drug Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 F Hoffmann-La Roche
-
13.1.1 F Hoffmann-La Roche Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Pfizer
-
13.2.1 Pfizer Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Eli Lilly
-
13.3.1 Eli Lilly Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 GSK
-
13.4.1 GSK Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Novartis
-
13.5.1 Novartis Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Johnson & Johnson
-
13.6.1 Johnson & Johnson Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Celltrion
-
13.7.1 Celltrion Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Arthritis Drug Market Size and Growth Rate of Synthetic DMARDs from 2016 to 2027
-
Figure China Arthritis Drug Market Size and Growth Rate of Biological DMARDs from 2016 to 2027
-
Figure China Arthritis Drug Market Size and Growth Rate of NSAIDs from 2016 to 2027
-
Figure China Arthritis Drug Market Size and Growth Rate of Corticosteroids from 2016 to 2027
-
Figure China Arthritis Drug Market Size and Growth Rate of Analgesics from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Arthritis Drug Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
Figure China Arthritis Drug Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027
-
Figure China Arthritis Drug Market Size and Growth Rate of Drug Stores from 2016 to 2027
-
Figure China Arthritis Drug Market Size and Growth Rate of E-Commerce from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Arthritis Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Arthritis Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Arthritis Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Arthritis Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Arthritis Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Arthritis Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Arthritis Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Arthritis Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Arthritis Drug
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Arthritis Drug by Different Types from 2016 to 2027
-
Table Consumption Share of Arthritis Drug by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Synthetic DMARDs
-
Figure Market Size and Growth Rate of Biological DMARDs
-
Figure Market Size and Growth Rate of NSAIDs
-
Figure Market Size and Growth Rate of Corticosteroids
-
Figure Market Size and Growth Rate of Analgesics
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Arthritis Drug by Different End-Users from 2016 to 2027
-
Table Consumption Share of Arthritis Drug by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Retail Pharmacies
-
Figure Market Size and Growth Rate of Hospital Pharmacies
-
Figure Market Size and Growth Rate of Drug Stores
-
Figure Market Size and Growth Rate of E-Commerce
-
Table China Arthritis Drug Production by Regions
-
Table China Arthritis Drug Production Share by Regions
-
Figure China Arthritis Drug Production Share by Regions in 2016
-
Figure China Arthritis Drug Production Share by Regions in 2021
-
Figure China Arthritis Drug Production Share by Regions in 2027
-
Table China Arthritis Drug Consumption by Regions
-
Table China Arthritis Drug Consumption Share by Regions
-
Figure China Arthritis Drug Consumption Share by Regions in 2016
-
Figure China Arthritis Drug Consumption Share by Regions in 2021
-
Figure China Arthritis Drug Consumption Share by Regions in 2027
-
Table North China Arthritis Drug Consumption by Types from 2016 to 2027
-
Table North China Arthritis Drug Consumption Share by Types from 2016 to 2027
-
Figure North China Arthritis Drug Consumption Share by Types in 2016
-
Figure North China Arthritis Drug Consumption Share by Types in 2021
-
Figure North China Arthritis Drug Consumption Share by Types in 2027
-
Table North China Arthritis Drug Consumption by End-Users from 2016 to 2027
-
Table North China Arthritis Drug Consumption Share by End-Users from 2016 to 2027
-
Figure North China Arthritis Drug Consumption Share by End-Users in 2016
-
Figure North China Arthritis Drug Consumption Share by End-Users in 2021
-
Figure North China Arthritis Drug Consumption Share by End-Users in 2027
-
Table Central China Arthritis Drug Consumption by Types from 2016 to 2027
-
Table Central China Arthritis Drug Consumption Share by Types from 2016 to 2027
-
Figure Central China Arthritis Drug Consumption Share by Types in 2016
-
Figure Central China Arthritis Drug Consumption Share by Types in 2021
-
Figure Central China Arthritis Drug Consumption Share by Types in 2027
-
Table Central China Arthritis Drug Consumption by End-Users from 2016 to 2027
-
Table Central China Arthritis Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Arthritis Drug Consumption Share by End-Users in 2016
-
Figure Central China Arthritis Drug Consumption Share by End-Users in 2021
-
Figure Central China Arthritis Drug Consumption Share by End-Users in 2027
-
Table South China Arthritis Drug Consumption by Types from 2016 to 2027
-
Table South China Arthritis Drug Consumption Share by Types from 2016 to 2027
-
Figure South China Arthritis Drug Consumption Share by Types in 2016
-
Figure South China Arthritis Drug Consumption Share by Types in 2021
-
Figure South China Arthritis Drug Consumption Share by Types in 2027
-
Table South China Arthritis Drug Consumption by End-Users from 2016 to 2027
-
Table South China Arthritis Drug Consumption Share by End-Users from 2016 to 2027
-
Figure South China Arthritis Drug Consumption Share by End-Users in 2016
-
Figure South China Arthritis Drug Consumption Share by End-Users in 2021
-
Figure South China Arthritis Drug Consumption Share by End-Users in 2027
-
Table East China Arthritis Drug Consumption by Types from 2016 to 2027
-
Table East China Arthritis Drug Consumption Share by Types from 2016 to 2027
-
Figure East China Arthritis Drug Consumption Share by Types in 2016
-
Figure East China Arthritis Drug Consumption Share by Types in 2021
-
Figure East China Arthritis Drug Consumption Share by Types in 2027
-
Table East China Arthritis Drug Consumption by End-Users from 2016 to 2027
-
Table East China Arthritis Drug Consumption Share by End-Users from 2016 to 2027
-
Figure East China Arthritis Drug Consumption Share by End-Users in 2016
-
Figure East China Arthritis Drug Consumption Share by End-Users in 2021
-
Figure East China Arthritis Drug Consumption Share by End-Users in 2027
-
Table Northeast China Arthritis Drug Consumption by Types from 2016 to 2027
-
Table Northeast China Arthritis Drug Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Arthritis Drug Consumption Share by Types in 2016
-
Figure Northeast China Arthritis Drug Consumption Share by Types in 2021
-
Figure Northeast China Arthritis Drug Consumption Share by Types in 2027
-
Table Northeast China Arthritis Drug Consumption by End-Users from 2016 to 2027
-
Table Northeast China Arthritis Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Arthritis Drug Consumption Share by End-Users in 2016
-
Figure Northeast China Arthritis Drug Consumption Share by End-Users in 2021
-
Figure Northeast China Arthritis Drug Consumption Share by End-Users in 2027
-
Table Southwest China Arthritis Drug Consumption by Types from 2016 to 2027
-
Table Southwest China Arthritis Drug Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Arthritis Drug Consumption Share by Types in 2016
-
Figure Southwest China Arthritis Drug Consumption Share by Types in 2021
-
Figure Southwest China Arthritis Drug Consumption Share by Types in 2027
-
Table Southwest China Arthritis Drug Consumption by End-Users from 2016 to 2027
-
Table Southwest China Arthritis Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Arthritis Drug Consumption Share by End-Users in 2016
-
Figure Southwest China Arthritis Drug Consumption Share by End-Users in 2021
-
Figure Southwest China Arthritis Drug Consumption Share by End-Users in 2027
-
Table Northwest China Arthritis Drug Consumption by Types from 2016 to 2027
-
Table Northwest China Arthritis Drug Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Arthritis Drug Consumption Share by Types in 2016
-
Figure Northwest China Arthritis Drug Consumption Share by Types in 2021
-
Figure Northwest China Arthritis Drug Consumption Share by Types in 2027
-
Table Northwest China Arthritis Drug Consumption by End-Users from 2016 to 2027
-
Table Northwest China Arthritis Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Arthritis Drug Consumption Share by End-Users in 2016
-
Figure Northwest China Arthritis Drug Consumption Share by End-Users in 2021
-
Figure Northwest China Arthritis Drug Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of F Hoffmann-La Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche
-
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche
-
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche
-
Table Product and Service Introduction of F Hoffmann-La Roche
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of GSK
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK
-
Figure Sales and Growth Rate Analysis of GSK
-
Figure Revenue and Market Share Analysis of GSK
-
Table Product and Service Introduction of GSK
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of Celltrion
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion
-
Figure Sales and Growth Rate Analysis of Celltrion
-
Figure Revenue and Market Share Analysis of Celltrion
-
Table Product and Service Introduction of Celltrion
-
